Back to Search
Start Over
Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities.
- Source :
-
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2023 Nov; Vol. 103, pp. 102778. Date of Electronic Publication: 2023 Jun 22. - Publication Year :
- 2023
-
Abstract
- Nineteen reports of 41 cases of acquired red cell elliptocytosis associated with a chronic myeloid neoplasm are described. Although the majority of cases have an abnormality of the long arm of chromosome 20, del(q20), several cases do not. Moreover, in one case a specific qualitative abnormality of red cell protein band 4.1(4.1R) was reported; however, several subsequent cases could find no abnormality of a red cell membrane protein or found a different abnormality, usually quantitative. Thus, this striking red cell phenotypic feature, acquired elliptocytosis, seen in myelodysplastic syndrome and other chronic myeloproliferative diseases, closely simulating the red cell phenotype of hereditary elliptocytosis, has an unexplained genetic basis, presumably as the result of an acquired mutation(s) in some chronic myeloid neoplasms.<br />Competing Interests: Declaration of competing interest None for both Drs. Lichtman and Sham.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Membrane Proteins genetics
Erythrocytes metabolism
Erythrocyte Membrane metabolism
Cytoskeletal Proteins genetics
Elliptocytosis, Hereditary complications
Elliptocytosis, Hereditary genetics
Neoplasms metabolism
Myeloproliferative Disorders complications
Myeloproliferative Disorders genetics
Myeloproliferative Disorders metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1096-0961
- Volume :
- 103
- Database :
- MEDLINE
- Journal :
- Blood cells, molecules & diseases
- Publication Type :
- Academic Journal
- Accession number :
- 37379758
- Full Text :
- https://doi.org/10.1016/j.bcmd.2023.102778